Results 31 to 40 of about 12,086 (222)
TITANIUM NANOPARTICLES CONJUGATED WITH STREPTOKINASE AS A MODIFIED THROMBOLYTIC AGENT [PDF]
Objective: Blood clots are the main cause of death worldwide by stroke and myocardial infarction. Streptokinase a thrombolytic agent that is used in the treatment of circulatory disorders.
ABED, HAYDER H. +2 more
core +1 more source
Background. Atrial fibrillation (AF) is a common arrhythmia after acute myocardial infarction (AMI).Mortality in AMI patients with AF also been shown to be up to twice as high as for those without AF.
Manoefris Kasim +2 more
doaj +1 more source
Synthesis, characterization and thrombolytic activity of n-benzyl piperidin 4-one phenyl hydrazone [PDF]
The aim of this study was to synthesize, characterization and thrombolytic activity of N-Benzyl piperidin 4-one phenyl hydrazone derivative. Check the purity of all the synthesized compounds using thin layer chromatography.
Tharini, K. +2 more
core +1 more source
Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model [PDF]
Cardiovascular disorders, including acute myocardial infarction (AMI), often lead to blood clot formation, impacting blood circulation. Streptokinase, a cost-effective and widely available thrombolytic agent, is crucial in treating thrombosis. This study
S. Yousaf +6 more
doaj +1 more source
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis [PDF]
Background: Meta-analyses of trials have shown greater benefits from angioplasty than thrombolysis after an acute myocardial infarction, but the time delay in initiating angioplasty needs to be considered.
E. Fenwick +20 more
core +1 more source
Presented case report demonstrates the efficacy and safety of hospital use of thrombolytic agent Fortelizin in pharmaco-invasive strategy for the treatment of a patient with acute myocardial infarction and with a long history of ischemic heart disease ...
N. T. Vatutin +3 more
doaj +1 more source
Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism [PDF]
Thrombolytic treatment accelerates the dissolution of thrombus in acute pulmonary thromboembolism (PTE) and is potentially a lifesaving treatment. High-risk PTE is the clearest indication for this therapy, and its use in intermediate-risk cases is still ...
YILMAZEL UÇAR, Elif, Elif Yilmazel Ucar
core +1 more source
The lecture is devoted to the choice of tactics and the rules of reperfusion therapy for ST-elevated myocardial infarction. Since the time of reperfusion is crucial for the survival of these patients and the preservation of a viable myocardium, proper ...
M. G. Glezer, E. I. Astashkin
doaj +1 more source
Thrombolytic therapy of pulmonary embolism A meta-analysis [PDF]
ObjectivesWe sought to assess the efficacy and safety of thrombolytic therapy in patients with an acute pulmonary embolism (PE).BackgroundThrombolytic therapy is approved for the treatment of acute PE; however, the safety and efficacy of this therapy ...
Bernard-Chabert, Brigitte +6 more
core +1 more source
Summary:. While the use of free flaps has become routine and is associated with a low complication rate, pedicled flaps remain a solid reconstructive option in various clinical situations.
Kosuke Maitani, MD +5 more
doaj +1 more source

